SepsisNCT05059808
European Sepsis Care Survey
An observational study of Sepsis, run by University Medicine Greifswald at 20 sites in 20 countries.
Trial summary
The objective of this survey is to investigate the current state of sepsis care around Europe. The study is aiming at hospital structure, emergency departments, wards, intensive care units and clinical diagnostic and microbiological service. Read more about this study
- Who is it for?
- Any age
- Conditions the study is for
- Sepsis
- How many people
- 1,450 participants
- Where
- 20 sitesin 20 countries
- Study dates
- 1 Aug 2021to 30 Oct 2022
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- No healthy volunteers
- Child, Adult, Older adult
Study population: European hospitals
Who may be able to join
- Hospitals of all strata
Who cannot join
- -
Trial locations and contacts
20 sites in 20 countries.
20 sites in 20 countries
Czechia1 site
Department of Anesthesiology and Intensive Care Medicine University Hospital of Ostrava
Ostrava-Poruba
Denmark1 site
Department of Emergency Medicine University of Southern Denmark
Odense
Finland1 site
Perioperative, Intensive Care and Pain Medicine Helsinki University Hospital
Helsinki
Greece1 site
4th Department of Internal Medicine ATTIKON University Hospital
Athens
Israel1 site
National Institute for Antibiotic Resistance & Infection Control, Ministry of Health
Tel Aviv
Moldova1 site
State University of Medicine and Pharmaceutics "Nicolae Testemiţanu"
Chisinau
Poland1 site
Department of Anaesthesiology and Intensive Therapy Wroclaw Medical University
Wroclaw
Romania1 site
"Prof CC Iliescu" Emergency Institute for Cardiovascular Diseases, Bucharest
Bucharest
Russia1 site
Vladimir L. Vanevskii Department of Anaesthesiology and Reanimatology, North-Western State Medical University named after Ilya I. Mechnikov
Saint Petersburg
Spain1 site
Corporació Sanitària Parc Taulí · critical care center, sabadell hospital, Corporació Sanitaria Universitaria Parc Tauli
Sabadell
Sweden1 site
Faculty of Medicine, Department of Clinical Sciences Lund, Division of Infection Medicine, Lund University
Lund
Turkey (Türkiye)1 site
Hacettepe University, Department of Internal Medicine Sihhiye, Ankara
Ankara
United Kingdom1 site
King's College London, Guy's and St Thomas' Foundation Hospital, Department of Critical Care, London
London
About this study
The objective of this survey is to investigate the current state of sepsis care around Europe. The study is aiming at hospital structure, emergency departments, wards, intensive care units and clinical diagnostic and microbiological service.
- Conditions
- Sepsis
- Medical subject headings
- Sepsis
What is being measured
The primary outcome is the main question the study is designed to answer.
Questionnaire
Structure of sepsis care in Europe
Measured: 2021
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted28 Sep 2021
- Study start1 Aug 2021
- Primary completion30 Apr 2022
- Study completion30 Oct 2022
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (2)Papers the sponsor has linked to this study.
- Other trials for SepsisStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Cross-sectional
- Enrolment
- 1,450 participants (actual)
Sponsor and investigators
- Lead sponsor
- University Medicine Greifswald
- Sponsor type
- University, hospital or other
- Collaborators
- European Sepsis Alliance, European Society of Anaesthesiology and Intensive Care, European Society for Emergency Medicine (EUSEM) Research Network, European Society of Clinical Microbiology and Infectious Diseases, ESGBIES Study Group, European Society of Intensive Care Medicine, Sepsisdialog, Germany, European Shock Society, Becton, Dickinson and Company
- Responsible party
- Principal investigator, Christian S. Scheer, MD, University Medicine Greifswald
- Investigators
- Christian S Scheer, Principal investigator, Anesthesiology and Intensive Care Medicine Department, University of Greifswald, GermanyAdam Linder, Principal investigator, European Sepsis AllianceDaniela Filipescu, Principal investigator, European Sepsis Alliance, European Society of Anaesthesiology and Intensive CareEvangelos Giamarellos-Bourboulis, Principal investigator, European Sepsis Alliance, European Shock SocietyEvgeny Idelevich, Principal investigator, ESCMID/Study Group for Bloodstream Infections, Endocarditis and SepsisKonrad Reinhart, Principal investigator, Global Sepsis AllianceMatthias Gründling, Principal investigator, Quality management project SepsisdialogRicard Ferrer, Principal investigator, European Society of Intensive Care Medicine
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05059808
- Sponsor's protocol ID
- ESA_Survey01
- Other IDs
- BB 124/21
- Status last verified
- Jun 2023
- First submitted
- 31 Aug 2021
- Last updated
- 13 Jun 2023
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: This study uses no patient data.
Publications
Smiechowicz J, Scheer CS, Bartczak J, Bartkowska-Sniatkowska A, Bascik K, Czaban SL, Czempik PF, Dabrowski W, Galuszka R, Gawor M, Gruszczyk J, Hasak L, Janc J, Jaworski M, Lubonski J, Mikaszewska-Sokolewicz M, Musiuk T, Smuszkiewicz P, Stefanska-Wronka K, Spiewak M, Szmigielska R, Talalaj M, Tkaczyk L, Wasiak W, Wojtowicz R, Wujtewicz M, Zorska J, Adamik B. Sepsis Recognition and Management Gaps in Hospitals: A Post Hoc Analysis of a Subset of Data from the European Sepsis Care Survey. Infect Dis Ther. 2026 Aug;15(8):2181-2198. doi: 10.1007/s40121-026-01387-4. Epub 2026 Jun 19.
PubMed 42319731Ceccato A, Scheer CS, Ferrer R, Martinez ML, Cistero B, Yebenes JC, Trenado J, Lorencio C, Linder A, Filipescu D, Idelevich EA, Giamarellos-Bourboulis EJ, Artigas A; European Sepsis Care Study Group. Regional sepsis care in Catalonia: comparative insights from a secondary analysis of the European Sepsis Care Survey. Crit Care. 2025 Aug 19;29(1):367. doi: 10.1186/s13054-025-05507-3. No abstract available.
PubMed 40830495
Study at a glance
From the registry record, last updated by the sponsor on 13 Jun 2023. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- European Sepsis Care Survey
- ClinicalTrials.gov ID
- NCT05059808
- Acronym / sponsor ID
- ESA_Survey01
- Conditions
- Sepsis
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 1,450 participants (actual)
- Lead sponsor
- University Medicine GreifswaldUniversity, hospital or other
- Collaborators
- European Sepsis Alliance, European Society of Anaesthesiology and Intensive Care, European Society for Emergency Medicine (EUSEM) Research Network, European Society of Clinical Microbiology and Infectious Diseases, ESGBIES Study Group, European Society of Intensive Care Medicine, Sepsisdialog, Germany, European Shock Society, Becton, Dickinson and Company
- Study start
- 1 Aug 2021 (actual)
- Primary completion
- 30 Apr 2022 (actual)
- Study completion
- 30 Oct 2022 (actual)
- First posted
- 28 Sep 2021 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The objective of this survey is to investigate the current state of sepsis care around Europe. The study is aiming at hospital structure, emergency departments, wards, intensive care units and clinical diagnostic and microbiological service.
Study design
- Observational model
- Other
- Time perspective
- Cross-sectional
Who may qualify
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult, Older adult
- Study population
- European hospitals
Key inclusion criteria (1 listed)
- Hospitals of all strata
Key exclusion criteria (1 listed)
- -
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Questionnaire
Time frame: 2021
Structure of sepsis care in Europe
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 13 Jun 2023.
- Derived from this study: PubMed 42319731Smiechowicz J, Scheer CS, Bartczak J, Bartkowska-Sniatkowska A, Bascik K, Czaban SL, Czempik PF, Dabrowski W, Galuszka R, Gawor M, Gruszczyk J, Hasak L, Janc J, Jaworski M, Lubonski J, Mikaszewska-Sokolewicz M, Musiuk T, Smuszkiewicz P, Stefanska-Wronka K, Spiewak M, Szmigielska R, Talalaj M, Tkaczyk L, Wasiak W, Wojtowicz R, Wujtewicz M, Zorska J, Adamik B. Sepsis Recognition and Management Gaps in Hospitals: A Post Hoc Analysis of a Subset of Data from the European Sepsis Care Survey. Infect Dis Ther. 2026 Aug;15(8):2181-2198. doi: 10.1007/s40121-026-01387-4. Epub 2026 Jun 19.
- Derived from this study: PubMed 40830495Ceccato A, Scheer CS, Ferrer R, Martinez ML, Cistero B, Yebenes JC, Trenado J, Lorencio C, Linder A, Filipescu D, Idelevich EA, Giamarellos-Bourboulis EJ, Artigas A; European Sepsis Care Study Group. Regional sepsis care in Catalonia: comparative insights from a secondary analysis of the European Sepsis Care Survey. Crit Care. 2025 Aug 19;29(1):367. doi: 10.1186/s13054-025-05507-3. No abstract available.
- Individual participant dataSharing planned: No. This study uses no patient data.
Related trials for Sepsis
Not yet recruitingPhase 2/3
A Pivotal Safety and Immunogenicity GBS-NN/NN2 Vaccine Maternal Immunisation Trial
Streptococcus Agalactiae Infection, Neonatal Sepsis
Active, not recruiting
CT for Personalized Mechanical Ventilation
Ventilator-Induced Lung Injury, Sepsis Syndrome
RecruitingPhase 4
A Study to Compare the Efficacy and Safety of Extended and Intermittent Infusion of Beta-lactams in Critically Ill Paediatric Patients
Infection, Sepsis
Not yet recruiting
Double Plasma Separation and Adsorption in Acute-on-Chronic Liver Failure (DPMAS-ACLF Trial)
Acute-on-Chronic Liver Failure (ACLF)
Active, not recruitingPhase 4
Thymosin Alpha 1 and IgM Levels in Sepsis
Sepsis, Septic Shock
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Christian S Scheer principal investigator
Anesthesiology and Intensive Care Medicine Department, University of Greifswald, Germany
Adam Linder principal investigator
European Sepsis Alliance
Daniela Filipescu principal investigator
European Sepsis Alliance, European Society of Anaesthesiology and Intensive Care
20 sites in 20 countries: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Sepsis, run by University Medicine Greifswald at 20 sites in 20 countries.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 13 Jun 2023. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 20 sites in Belgium, Czechia, Denmark, Finland, France and 15 more countries. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Questionnaire (time frame: 2021). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT05059808, which also lists 2 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Jun 2023.